Ikonisys Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Ikonisys's earnings have been declining at an average annual rate of -30.3%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 2.2% per year.
Información clave
-30.3%
Tasa de crecimiento de los beneficios
16.0%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 21.6% |
| Tasa de crecimiento de los ingresos | 2.2% |
| Rentabilidad financiera | -17.2% |
| Margen neto | -543.6% |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Ikonisys. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -3 | 2 | 0 |
| 31 Mar 24 | 0 | -2 | 1 | 0 |
| 31 Dec 23 | 0 | -2 | 1 | 0 |
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 1 | -2 | 2 | 0 |
| 31 Mar 23 | 1 | -2 | 2 | 0 |
| 31 Dec 22 | 1 | -2 | 2 | 0 |
| 30 Sep 22 | 1 | -2 | 2 | 0 |
| 30 Jun 22 | 1 | -1 | 1 | 0 |
| 31 Mar 22 | 1 | -1 | 1 | 0 |
| 31 Dec 21 | 1 | -1 | 1 | 0 |
| 30 Sep 21 | 0 | -1 | 1 | 0 |
| 30 Jun 21 | 0 | -1 | 0 | 0 |
| 31 Mar 21 | 0 | -1 | 0 | 0 |
| 31 Dec 20 | 0 | -2 | 0 | 0 |
Ingresos de calidad: ALIKO is currently unprofitable.
Margen de beneficios creciente: ALIKO is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ALIKO is unprofitable, and losses have increased over the past 5 years at a rate of 30.3% per year.
Acelerando crecimiento: Unable to compare ALIKO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: ALIKO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Rentabilidad financiera
Alta ROE: ALIKO has a negative Return on Equity (-17.16%), as it is currently unprofitable.